Nebulizers
National · Effective Feb 1, 2026
1 active Medicare policy lists J7686, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Feb 1, 2026
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J7686 |
|---|---|---|
| Iontophoresis | Apr 26, 2023 | Covered |
| Pulmonary Hypertension Treatments and Selected Indications of Prostanoids | Aug 30, 2023 | Covered |
| Policy | Effective | Status of J7686 |
|---|---|---|
| Treprostinil (Orenitram, Remodulin, Tyvaso, Tyvaso DPI, Yutrepia); CP.PHAR.199 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |